Cytomedix Announces CMS to Reconsider Coverage for Platelet Rich Plasma Technology (PrimeNewswire via Yahoo! Finance)
ROCKVILLE, Md., June 26, 2007 -- Cytomedix, Inc. today announced that the Centers for Medicare and Medicaid Services has agreed to Cytomedix's request to reconsider a non-coverage decision for autologous blood-derived products when used for the treatment of chronic non-healing wounds.

Health Canada Approves ADVR's Application for Clinical IND (RedNova)
Advanced Viral Research Corp. (OTCBB: ADVR), a

Safety And Statistically Significant Improvement In Parkinson's Disease Shown By Gene Therapy Study (Medical News Today)
Neurologix, Inc. (OTC Bulletin Board: NRGX) has announced in the journal The Lancet publication of positive results from the first ever gene therapy trial for Parkinson's disease and the first report of direct gene transfer into a patient's own brain cells for any adult neurodegenerative disease. [click link for full article]